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Abstract
Context: Various studies in Iran on the role of menopause and age at menarche in breast cancer reported different results.
Objectives: The current study aimed to estimate the overall odds ratio and explore the association between early menarche and
menopause with breast cancer.
Data Sources: Scopus, Web of Science, PubMed, Google Scholar and Iranian databases such as Magiran and SID, breast cancer key
journals (Asian pacific journal of cancer prevention, Iranian quarterly journal of breast) and conferences (international breast can-
cer congresses in Iran, annual breast cancer conferences and seminars in Iran) were searched from 2004 to 2014.
Study Selection: The observational studies in Iran that had reported the relationship between menopause and early menarche with
breast cancer were searched. The exposure was menopause and early menarche and the outcome was breast cancer with patholog-
ical confirmation.
Data Extraction: Using strengthening the reporting of observational studies in epidemiology (STROBE) checklist, quality assess-
ment of the articles and data extraction were performed separately by two authors.
Results: Of 4396 articles, 12 studies with a sample size of 27734, 11 studies with a sample size of 4039 and 20 studies with a sample size
of 53417 were analyzed to estimate the overall odds ratio (OR) for early menarche and the standardized mean difference (SMD) of the
average menarche age and overall OR of menopause, respectively. A significant relationship was observed between early menarche
and breast cancer (OR = 1.57, 95% confidence interval (CI) = 1.05, 2.34). The mean menarche age in patients was also significantly
lower than in healthy females (SMD = -0.087, 95%CI = -0.151, -0.02). Postmenopausal female had a higher risk for developing breast
cancer; however, this relationship was not statistically significant (OR=1.35, 95%CI=0.98, 1.86).
Conclusions: Menopause and early menarche increase the odds of breast cancer. Therefore, breast cancer prevention and screening
programs are needed to reduce the burden of this cancer and improve the quality of females‘ lives.
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1. Context
Breast cancer is the most common type of cancer
among females both in the developed and developing
countries. The increased rate of breast cancer in the de-
veloping countries is attributed to the increased life ex-
pectancy, urbanization and westernization of lifestyle (1).
According to the international agency for research on can-
cer (IARC), since 2008 the incidence and mortality of breast
cancer increased by 20% and 14%, respectively. This type of
cancer is the most common cause of cancer death among
females accounted for 522,000 deaths in 2012 (2). Various
risk factors for breast cancer are identified. However, no
specific risk factor is identified for a large number of pa-
tients (3). Reproductive risk factors, old age at the first
birth, use of oral contraceptive pills or hormone replace-
ment therapy are among the most important risk factors
for breast cancer (4). Recently, in a systematic review and
meta-analysis, Narimanian et al. investigated the risk fac-
tors for breast cancer in the Eastern Mediterranean re-
gion and considered the early menarche as a risk factor
for breast cancer. However, given the reported effect size
(pooled odds ratio (OR) = 1.12, 95% confidence interval (CI)
= 0.97, 1.28), no significant relationship was found. The
selected studies were the ones published in English lan-
guage, their full text were freely accessible and reporting
OR and relative risk (5). However, Narimanian et al. (5) did
not include Persian and cross-sectional studies in their re-
view.
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Various studies in Iran on the relationship between
breast cancer and menopause and age at menarche re-
ported different results. Thus, due to the aging population
and the decreasing age of menarche in Iranian females and
the role of these risk factors in breast cancer; the current
study was conducted to determine overall estimates for
these risk factors, in terms of OR. The main questions of
the study were: “Is early menarche associated with risk of
developing breast cancer in females?” “Is the risk of breast
cancer in postmenopausal females higher than that of the
premenopausal ones?”
2. Data Sources
The current meta-analysis aimed to determine all
observational studies on the relationship between
menopause, and age at menarche with breast cancer.
All observational studies including cohort, case-control
and cross-sectional studies on the relationship between
these risk factors and breast cancer in Iran, published in
Persian or English (from 2004 to 2014) were searched. To
identify cancer synonyms, the medical subject headings
(MeSH) was searched using the keywords of cancer, tumor,
neoplasm, neoplasia, carcinoma, malignancy, malignant
and benign. A combination of the above-mentioned words
were used with OR and then the words Iran and breast
were added to the search field using the operator AND.
The electronic databases of PubMed, Web of Sci-
ence, Scopus (search date: 2015/05/11), Google Scholar
and Iranian scientific electronic databases (search date:
2015/04/19) such as SID (in English and Persian languages)
and Magiran (in Persian language) were searched. More-
over, the references of the selected articles and the ab-
stracts of the articles presented at the international breast
cancer congresses in Iran, annual breast cancer confer-
ences and seminars in Iran, Iranian quarterly journal of
breast disease (from the first issue to the end of March
2015), and the Asian pacific journal of cancer prevention
from the first issue in 2004 to the end of 2014) were re-
viewed. To find the texts of the articles from the con-
gresses, seminars and conferences, the corresponding au-
thors were contracted. Moreover, the Irandoc data base
was reviewed for thesis, but this database was incomplete.
Therefore the authors tried to access the research project
by requesting them from Iranian university libraries, but
no response was received.
3. Study Selection
The observational studies (cohort, case-control and
cross-sectional) on the relationship between age at menar-
che and menopause with breast cancer published in Per-
sian and English from 2004 to 2014 were included in the
study. The exposures included age at menarche≤ 13 years
and menopause in females. The studies conducted only
on patients were excluded. There were no limitations in
terms of age and race, and no comparison was made. Age at
menarche is defined the age that first menstrual cycle hap-
pens in females. Menopause is also defined as an event in
females‘ lives which occurs when menstrual periods stop
permanently due to the cessation of ovarian activity. The
desired outcome of this study was breast cancer (of any
type), confirmed by the pathology report. Therefore, all
types of breast cancer, regardless of their pathological fea-
tures and tumors’ stage, were included in this study. In
all of the reviewed studies, controls were females without
breast cancer. Two authors (Zahmatkesh and Khosravi) re-
viewed the obtained articles in terms of the inclusion crite-
ria. The articles were not blind in terms of authors’ names,
journal’s name and results. Any disagreement between the
two authors was reviewed by the third author (Chaman).
The strengthening the reporting of observational studies
in epidemiology (STROBE) checklist was used to assess the
risk of bias and to score the quality of studies, indepen-
dently. Then the articles with a score ≥ 6 were selected.
Some of the criteria of the STROBE checklist that were used
to assess the articles were as follows: methods (setting, par-
ticipants, variables, data sources/measurement, bias), re-
sults (main results) and discussion (limitation, generality).
The study selection process is presented in the Figure 1.
4. Data Extraction
Two authors extracted the data of the included articles.
The extracted variables included publication year, authors’
name, type of the study, sample size, population age, age at
menarche (the mean age at menarche and age groups for
menarche), menopausal status, matching status, number
of cases with breast cancer, and number of controls. The
extracted data were transferred into the software, and the
author was corresponded with in cases where lack of some
data was encountered.
5. Measures of Exposure Effect and Data Analysis
No cohort study on the issue was available from Iran
and only case-control and cross-sectional studies were ob-
tained. Therefore, OR was selected as a criteria for the ef-
fect size. A meta-analysis with a 95%CI was used to obtain
the combined effect size. The analysis was performed us-
ing the STATA 11.2 software (Stata Corporation, College Sta-
tion, Texas, USA) and the results were reported using the
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Screened Records = 58 
Reminded Articles with Inclusion Criteria = 37 
Excluded because:  
Only abstracts were accessible or data 
could not be used = 8 
Not having the including criteria = 13 
After review and appraising articles: Totally data of 29 articles 
were selected: 
7 Articles had data of early menarche & menopause.                      
6 Articles had data of mean at age menarche & menopause.    
1 Article had data of mean at age menarche & early menarche.  
4 Articles had data of early menarche.
7 Articles had data of menopause. 
4 Articles had data of mean at age menarche.
                  
8 Articles excluded because:  
Matching at menarche age in case and 
control groups, control group had benign 
breast tumor, case group had benign & 
malignant breast tumor, 
 Data could not be used and similar data. 
Excluded because not having the inclusion 
criteria = 436 
After Duplicates Removed = 494 
Records Identified Through International 
Database (PubMed, Scopus, ISI, Google 
Scholar) = 2196. 
Records Identified Through Iranian Database 
(Magiran and SID) = 2200 
Iranian Key Journals = 175 
Asian Pacific Journal of Cancer Prevention = 
3995 
Searching Trough Articles’ Reference = 1490 
Searching in Iranian Conferences = 289  
Searching in from International Conferences = 39
Figure 1. Flow Diagram of the Identification Process to Select Articles in the Review
random effects model. Statistical heterogeneity at a P value
< 0.05 was determined using the Chi-square test. Within-
study and between-study inconsistency or variation were
estimated using the I2 (6) and the Tau2 (7) statistics respec-
tively. The Begg and the Egger statistical tests were used to
show the publication bias.
6. Results
6.1. Description of the Studies
A total of 4396 articles were obtained from the Iranian
and international databases. Of these, 2200 and 2196 arti-
cles were from Iranian and international databases, respec-
tively. After exclusion of duplicated articles and reviewing
the titles and abstracts of the remained articles, 28 articles
from the international databases and 22 from the Iranian
databases remained.
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Reviewing the titles of the articles presented at confer-
ences held in Iran (i e, the 4th - 10th international breast
cancer congresses in Iran as well as the 2th - 7th national
breast cancer congresses in Iran) showed 289 relevant arti-
cles. However, after reviewing the abstracts, seven articles
were added to the previous ones.
All issues of the Iranian quarterly journal of breast dis-
ease (up to the end of March 2015) were also reviewed, and
four articles were relevant whose full texts had been ob-
tained previously. Asian pacific journal of cancer preven-
tion (from 2004 to 2014) was also reviewed and of the 3995
articles, ten were relevant, among which nine had been
obtained previously and one new article was added to the
list of the selected articles. Therefore, a total of 58 articles
were included in the review but 50 articles were accessible
with their full texts. About the other eight articles, the cor-
responding authors were emailed three times, but no re-
sponse was received. As the data presented in these eight
abstracts could not be used in the meta-analysis, they were
excluded. The references of the articles whose full texts
were accessible were also reviewed, and 51 articles were
relevant that had been found in the previous search re-
sults. Therefore, 50 articles with accessible full texts were
obtained and after review of full texts, 13 articles did not
have the including criteria or data of menopause and age
at menarche; therefore were excluded and 37 articles re-
minded.
Of the 37 reviewed articles, 32 articles reported the data
of age at menarche, among which 14 articles presented the
average age at menarche in the case and the control groups
(8-21). In two articles, the case and the control groups had
been matched in terms of the average age at menarche (19,
20), and in one article the control group had benign breast
tumor (21), therefore the three later studies were excluded
from the analysis. Finally, 11 articles included in the meta-
analysis to estimate standard mean difference of menar-
che age.
To estimate pooled OR early menarche, of 37 articles,
the article by Motamed et al. only reported the OR with-
out CI (22), and the article by Dadashi et al. only reported
the OR for early menarche without giving any definition of
early menarche (23). Therefore these two articles were ex-
cluded from the analysis.
In 18 articles, the data of age at menarche were reported
in terms of age groups (qualitatively) (18, 24-40). Three ar-
ticles had similar data (24-26) and therefore only one of
them was included in the analysis. Among these articles,
one article reported the data of age at menarche both aver-
agely and qualitatively.
According to the study by Mohsenzadeh-ledari et al.
the average age at menarche of females in Iran was about
13 years (41). Therefore, the data of the articles were divided
into 13 < and 13 ≥ age groups. The data of three articles
could not be used for meta-analysis. One article also had a
wide confidence interval (27) and was excluded. Thus 12 ar-
ticles included in meta-analysis to estimate the pooled OR
of early menarche.
Of the 37 articles with full texts, 25 articles considered
menopause as a risk factor for breast cancer in females.
Two articles were excluded from the analysis since in one
of them all subjects were aged ≤ 50 years (29) and in an-
other article all females were aged over 50 years old (28).
The data of three articles (24-26) were similar as they were
resulted of a similar work. Therefore, only the data of one
article (26) was included in the analysis. One article was ex-
cluded since the control group had benign breast tumor
(21). Therefore 20 articles included in the meta-analysis to
estimate pooled OR of menopause.
6.2. Association Between Early Menarche and Breast Cancer
The data of 12 case-control articles with a total sam-
ple size of 27704 individuals (case = 2020, control = 25684)
were included in the meta-analysis to estimate the com-
bined OR (Table 1) (18, 24, 30-36, 38-40).
The results showed that the odds of breast cancer was
significantly higher in the females with menarche age ≤
13 years than in those with higher menarche age (OR = 1.57,
95%CI = 1.05, 2.34) (Figure 2).
6.3. Comparison the Average Age at Menarche Between Breast
Cancer Patients and Healthy Females
The data of 11 articles, which had the data of mean
at menarche age, with a sample size of 4039 individuals,
which had pointed out the average age at menarche, were
included in the analysis (Table 2) (8-18). The standardized
mean difference (SMD) of the age at menarche in the two
groups (breast cancer patients and healthy females) indi-
cated that the average age at menarche in the breast can-
cer group was significantly lower than that of the healthy
females (SMD = -0.087, 95% CI = -0.15, -0.02) (Figure 3).
6.4. Association Between Menopause and Breast Cancer
Finally, twenty case-control studies with a sample size
of 53417 were analyzed to estimate the OR (8, 9, 11, 13, 15,
17, 26, 27, 31, 33-37, 39, 40, 42-45). Of these, 17 studies were
hospital-based and three were population-based (13, 27,
44).
The results of meta-analysis showed that menopause
was a risk factor for breast cancer. In other words, the odds
of breast cancer was higher in postmenopausal females
than in premenopausal ones; however, this relationship
was not statistically significant (OR = 1.36, 95%CI = 0.97, 1.91)
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Table 1. Meta-Analysis Odds Ratio for Menarche Age≤ 13 Years Old and Risk for Breast Cancer Using the Random Effects Method
Author Year Total Sample Size Number of Cases Number of Controls OR 95% Confidence Interval Weight, %
Hajian-Tilaki et al. (24) 2012 300 100 200 0.643 0.397, 1.042 8.66
Montazeri et al. (30) 2008 232 116 116 1.732 0.897, 3.346 7.81
Zare et al. (40) 2013 23440 98 23342 0.99 0.664, 1.475 9.02
Keihanian et al. (33) 2010 120 60 60 3 1.075, 8.37 6
Yavari et al. (39) 2005 599 298 301 1.262 0.852, 1.87 9.05
Tehranian et al. (38) 2010 624 312 312 4.017 2.769, 5.829 9.13
Tazhibi et al. (18) 2014 257 216 41 1.244 0.559, 2.769 7.1
Pourzand et al. (35) 2013 400 200 200 0.635 0.403, 1.003 8.78
Mahouri et al. (34) 2007 672 168 504 4.004 2.558, 6.267 8.81
Hosseinzadeh et al. (31) 2014 420 140 280 2.899 1.745, 4.817 8.55
Ghadiri et al. (32) 2013 353 174 179 1.328 0.816, 2.164 8.64
Saadat et al. (36) 2007 287 138 149 1.281 0.758, 2.166 8.46
Pooled OR 2020 25684 1.572 1.054, 2.344 100
NOTE: Weights are from random effects analysis
Overall (I-Squared = 87.0%, p = 0.000)
Saadat (2007)
Yavari  (2005)
Pourzand (2013)
Tehrnian (2010)
Ghadiri (2013)
Study
Tazhibi (2014)
keihania (2010)
Montazer (2008)
Zare (2013)
ID
Hoseinza (2014)
Hajian (2012)
Mahouri (2007)
1.57 (1.05, 2.34)
1.28 (0.76, 2.17)
1.26 (0.85, 1.87)
0.64 (0.40, 1.00)
4.02 (2.77, 5.83)
1.33 (0.82, 2.16)
1.24 (0.56, 2.77)
3.00 (1.08, 8.37)
1.73 (0.90, 3.35)
0.99 (0.66, 1.47)
OR (95% CI)
2.90 (1.74, 4.82)
0.64 (0.40, 1.04)
4.00 (2.56, 6.27)
100.00
8.46
9.05
8.78
9.13
8.64
%
7.10
6.00
7.81
9.02
Weight
8.55
8.66
8.81
  
1.119 8.37
Figure 2. Forest Plot Diagram of the Relationship Between Age at Menarche≤ 13 Years and Breast Cancer Using the Random Effects Method
(Table 3, Figure 4). In seven studies included in the meta-
analysis (17, 26, 34, 37, 42, 43, 45), this relationship was in-
verse and menopause was a protective factor, however, in
five studies, this relationship was not statistically signifi-
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Table 2. Meta-Analysis of the SMD of Age at Menarche in the Study Groups
Author Year Sample Size SMD 95% Confidence Interval Weight, %
Abbasi et al. (8) 2009 297 -0.207 -0.435, 0.021 8.1
Akbari et al. (9) 2010 801 -0.088 -0.227, 0.051 21.87
Azarshab and Bidgoli (10) 2014 176 -0.054 -0.365, 0.258 4.34
Bahadoran et al. (11) 2013 275 0.39 0.143, 0.638 6.86
Motie et al. (12) 2011 267 -0.218 -0.458, 0.023 7.28
Naieni et al. (13) 2007 750 -0.191 -0.343, -0.039 18.21
Nojomi et al. (14) 2004 580 -0.215 -0.401, -0.029 12.15
Sariri et al. (15) 2012 257 -0.038 -0.283, 0.207 7.05
Sharif Zadeh et al. (16) 2011 170 -0.134 -0.435, 0.167 4.65
Shokouhi et al. (17) 2008 209 0.129 -0.143, 0.4 5.71
Tazhibi et al. (18) 2014 257 0.091 -0.243, 0.425 3.78
Pooled SMD -0.087 -0.151, -0.022 100
Abbreviation: SMD, standard mean difference.
Overall  (I-Squared = 58.1%, p = 0.008)
Study
Abbasi (2009)
Akbari (2010)
Bahadora (2013)
ID
Sharifza (2011)
Shokouhi (2006)
Motie (2011)
Nojomi (2004)
Azarshab (2014)
Sariri (2012)
Tazhibi (2014)
Naieni (2007)
-0.09 (-0.15, -0.02)
-0.21 (-0.44, 0.02)
-0.09 (-0.23, 0.05)
0.39 (0.14, 0.64)
SMD (95% CI)
-0.13 (-0.44, 0.17)
0.13 (-0.14, 0.40)
-0.22 (-0.46, 0.02)
-0.22 (-0.40, -0.03)
-0.05 (-0.37, 0.26)
-0.04 (-0.28, 0.21)
0.09 (-0.24, 0.42)
-0.19 (-0.34, -0.04)
100.00
%
8.10
21.87
6.86
Weight
4.65
5.71
7.28
12.15
4.34
7.05
3.78
18.21
  
0-.638 .638
Figure 3. Forest Plot Diagram of the Difference Between Mean Age at Menarche Between Breast Cancer and Healthy Females
cant (17, 26, 34, 42, 45). On the other hand, 13 studies re-
ported that menopause was associated with increased risk
of breast cancer, however, in six articles this relationship
was not statistically significant (9, 11, 27, 31, 35, 36).
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Table 3. Meta-Analysis Results of Odds Ratio of Menopause Status on Breast Cancer Using the Random Effects Method
Study Year Sample Size OR 95% Confidence Interval Weight, %
Abbasi et al. (8) 2009 297 4.647 2.57, 8.399 4.89
Akbari et al. (9) 2010 801 1.104 0.831, 1.466 5.52
Besharat et al. (44) 2011 267 3.35 1.987, 5.649 5.06
Mobarakeh et al. (42) 2014 93 0.698 0.259, 1.883 3.86
Hajian et al. (26) 2013 300 0.755 0.466, 1.223 5.15
Hosseinzadeh et al. (31) 2014 420 1.476 0.982, 2.22 5.31
Keihanian et al. (33) 2010 120 3.237 1.529, 6.853 4.49
Lotfi et al. (27) 2008 140 1.494 0.762, 2.928 4.69
Mahouri et al. (34) 2007 672 0.946 0.667, 1.342 5.42
Naieni et al. (13) 2007 750 2.014 1.476, 2.749 5.48
Pourzand et al. (35) 2013 400 1.179 0.792, 1.754 5.33
Sariri et al. (15) 2012 257 4.697 2.741, 8.049 5.02
Shokouhi et al. (17) 2008 222 0.944 0.485, 1.838 4.71
Yavari et al. (39) 2005 600 2.991 2.106, 4.248 5.41
Zare et al. (40) 2013 35380 1.703 1.169, 2.481 5.37
Bahadoran et al. (11) 2013 275 1.019 0.612, 1.695 5.09
Saadat et al. (36) 2007 276 1.466 0.865, 2.486 5.05
Sepandi et al. (37) 2014 11850 0.317 0.237, 0.424 5.51
Rezaeian et al. (43) 2012 207 0.32 0.16, 0.637 4.65
Eftekhari et al. (45) 2009 90 0.796 0.312, 2.032 4
Pooled OR 1.36 0.968, 1.911 100
6.5. Heterogeneity and Publication Bias
To estimate the overall OR for the association of menar-
che age ≤ 13 years with breast cancer, between-study het-
erogeneity was measured using the Chi2 and I2 tests. Exam-
ining the risk factor of age at menarche≥ 13 years showed
that Chi2 = 84.38%, P < 0.001, I2 = 87%, and the difference
among studies or Tau2 = 0.42. Therefore, the results of the
present study were heterogeneous. Of 12 analyzed studies,
three reported an inverse relationship between menarche
age≤ 13 years and breast cancer, which was not significant
(24, 35, 40). Five studies reported a direct relationship be-
tween menarche age ≤ 13 years and breast cancer, which
was not significant (18, 30, 32, 36, 39). The four other stud-
ies reported a significant direct relationship between this
risk factor and breast cancer.
To estimate the SMD of menarche age between patients
with breast cancer and healthy females, the between-study
heterogeneity was measured using the Chi2 and I2 tests. Ex-
amining the risk factor of age at menarche showed that
Chi2 = 23.86%, P < 0.009, and I2 = 58.1%. Therefore, the het-
erogeneity of the present study was average. In three ar-
ticles, the average age at menarche in the patients with
breast cancer was higher than that of the healthy females
(11, 17, 18). However, this difference was not statistically sig-
nificant in the last two studies. In eight studies, the aver-
age age at menarche in the patients with breast cancer was
lower than that of the healthy females, and in six studies
this difference was not significant (8-10, 12, 15, 16)
To estimate the overall OR for the association of
menopause and breast cancer, between-study heterogene-
ity was measured using the Chi2 and I2 tests. The results
showed that the studies were heterogeneous, Chi2 = 210.66,
P < 0.001 and I2 = 91%. Therefore, there was extreme hetero-
geneity in the current study and Tau2 = 0.52. After divid-
ing the studies into subgroups based on the type of stud-
ies, the heterogeneity of hospital-based case-control stud-
ies did not change (I2 = 91%) and the heterogeneity of three
population-based case-control studies changed (I2 = 50.7%).
After using meta-regression for the variable of type of stud-
ies, the remaining I2 was calculated as 90.48%, which in-
dicated the existence of heterogeneity. Moreover, the ad-
justed R-squared was 2.44% which showed that the type of
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NOTE: Weights are from random effects analysis
Overall (I-Squared = 91.0%, p = 0.000)
Shokouhi (2008)
Eftekhar (2009)
Bahadora (2013)
Rezaeian (2012)
Sepandi (2014)
Pourzand (2013)
Lotfi (2008)
Zare (2013)
Yavari (2005)
Abbasi (2009)
Naieni (2007)
Keihania (2010)
Hosseinz (2014)
Mahouri (2007)
Mobarake (2014)
Sariri (2012)
Saadat (2007)
Akbari (2010)
ID
Besharat (2011)
Hajian (2013)
Study
1.36 (0.97, 1.91)
0.94 (0.48, 1.84)
0.80 (0.31, 2.03)
1.02 (0.61, 1.70)
0.32 (0.16, 0.64)
0.32 (0.24, 0.42)
1.18 (0.79, 1.75)
1.49 (0.76, 2.93)
1.70 (1.17, 2.48)
2.99 (2.11, 4.25)
4.65 (2.57, 8.40)
2.01 (1.48, 2.75)
3.24 (1.53, 6.85)
1.48 (0.98, 2.22)
0.95 (0.67, 1.34)
0.70 (0.26, 1.88)
4.70 (2.74, 8.05)
1.47 (0.86, 2.49)
1.10 (0.83, 1.47)
OR (95% CI)
3.35 (1.99, 5.65)
0.75 (0.47, 1.22)
100.00
4.71
4.00
5.09
4.65
5.51
5.33
4.69
5.37
5.41
4.89
5.48
4.49
5.31
5.42
3.86
5.02
5.05
5.52
Weight
5.06
5.15
%
  
1.119 8.4
Figure 4. Forest Plot Diagram of the Relationship Between Menopause Status and Breast Cancer Using the Random Effects Method
studies play an insignificant role in heterogeneity (2.44%).
Publication bias was assessed using the Begg and the
Egger tests. Results of the Begg and the Egger tests and the
Egger test diagram showed lack of publication bias (Figure
5 - 7).
7. Discussion
Meta-analysis showed that menarche age≤ 13 years in-
creased the odds of breast cancer in Iranian females. This
finding was consistent with that of a previous study by Sar-
mento de Almeida et al. (46). In a study by Namiranian et
al. age at menarche less than 12 years was considered as a
risk factor for breast cancer. However, the relationship was
not statistically significant (5). The reason for the inconsis-
tency might be due to the difference in the age at menar-
che and reviewed databases, examined areas and covering
Persian and English articles in the present study. In a sys-
tematic review, age at menarche ≥ 15 years was consid-
ered a protective factor against breast cancer, but menar-
che age < 13 years was not associated with breast cancer
(47). The later study covered the studies published till 2011,
and only used Cochrane and MEDLINE databases to search
randomized controlled trials (RCTs), observational studies,
systematic reviews and English meta-analyses. Moreover,
females were in the age range of 40 - 49. On the contrary,
the studies used in the present study were all case-control
studies and there were no such limitations as age range
for females. These differences were probably the reason for
determining the age at menarche≤ 13 years as the risk of
breast cancer in the present study. A study by Besharat et
al. showed that age at menarche < 13.37 years increased the
risk of breast cancer in females by 1.3 times; however, it was
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Figure 5. The Egger Test for the Publication Bias of the Relationship Between Menar-
che Age≤ 13 Years and Breast Cancer
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Figure 6. The Egger Test for the Publication Bias of the Difference in the Average Age
at Menarche Between the Two Groups (Breast Cancer Patients And Healthy Females)
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Figure 7. The Egger Test for the Publication Bias of the Relationship Between
Menopause and Breast Cancer
not statistically significant (44). The low sample size of the
study by Besharat et al. might be the reason for the differ-
ence between their results and the findings of the present
study. Results of a study by Babita et al. were also consis-
tent with those of the present study. They reported that fe-
males with age at menarche < 13 years were 3.7 times more
likely to develop breast cancer, while the age at menarche
> 15 was a protective factor for breast cancer (48).
The present study showed that the average age at
menarche in females with breast cancer was significantly
lower than that of healthy females. Consistently, a study
by Beral et al. also showed that lower age at menarche in-
creased the risk of breast cancer (49). However, Naieni et
al. (13), Besharat et al. (44) Sharifzadeh et al. and Tazhibi
et al. (16, 18) could not find any significant relationship
between age at menarche and breast cancer. Such an in-
consistency between these studies and the present study
might be attributed to the low sample size and also select-
ing the controls from the neighbors of the patients in some
of the aforementioned studies.
The results of meta-analysis showed that menopause
was a risk factor for breast cancer. In other words, the risk
of breast cancer was higher in postmenopausal females
than in premenopausal ones. However, this relationship
was not statistically significant. The results of the study
by Sarmento de Almedia were also consistent with those
of the current study (46). Bhadoria et al. in India re-
ported that the risk for breast cancer in postmenopausal
females was 2.5 times greater than in premenopausal fe-
males, and the difference was statistically significant (50).
In another study by Ishida et al., menopause increased the
risk of breast cancer by 2.65 times. However, the results
of their study were different after adjustment of age, and
menopause was considered a protective factor (51). Differ-
ences in race, lifestyle and methodology in studies might
be the reason for differences in the results.
Limitation of this meta-analysis was lack of access to
research projects and thesis related to the subject of the
study. It was tried to access these documents by request-
ing from Iranian university libraries, but no response was
received.
Given the decreasing trend in age of puberty and re-
gional differences as well as the country’s aging popu-
lation, increase of menopausal females’ population size
and increasing prevalence of overweight and obesity in fe-
males, more research is needed on these risk factors.
In conclusion, early menarche and menopause in-
creased the risk of breast cancer in Iranian females. Given
the average age at menarche in Iranian females (about 13
years), decreasing trend in menarche age in Iranian fe-
males, increasing trend in incidence of breast cancer (52),
increased life expectancy in females, and consequently in-
Nurs Midwifery Stud. 2017; 6(1):e37712. 9
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crease in the postmenopausal population, it is necessary
to design breast cancer prevention and control programs
more than ever.
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